Role of CTLA-4 blockade and dacarbazine therapy following anti-PD-1 resistance in melanoma
Abstract Many patients with advanced melanoma eventually stop responding to PD-1 immunotherapy, and effective treatments are limited. Recent studies suggest that older chemotherapy drugs such as dacarbazine and temozolomide may work better after prior PD-1 therapy and can stimulate the immune system...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer
2026-03-01
|
| סדרה: | Discover Oncology |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1007/s12672-026-04816-5 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|